IP is a core practice area for Taylor Wessing LLP globally, and that is reflected in the depth of expertise in the firm’s Cambridge office. Working closely with its highly regarded venture capital group, the IP team led by Adrian Toutoungi acts for numerous spin-outs, high-growth and multinational companies, including new ventures emerging from Cambridge University, as well as for investors. Its work encompasses cutting-edge deeptech sectors such as quantum computing, advanced semiconductor processor design, chips for large language model AI, and next generation battery technology. Toutoungi is respected for its work on life science licensing matters. Colin McCall is an IP commercialisation specialist, and Tasmina Goraya handles high-stakes litigation, regulatory and compliance issues. Charlie Adams is a rising star in our IP/patent commercialisation team.
Legal 500 Editorial commentary
Key clients
- Cumulus Oncology Limited
- Abbott Laboratories
- Antiverse Limited
- Biorek s.r.l.
- IQ Capital/Plural
- OPPO
- Diagnostics for the Real World
- PAION Pharma
Work highlights
Advised Antiverse on the negotiation of its multi-target partnership and licensing agreement with Nxera Pharma.
Advised the China headquartered PAION, on the roll-out of a new global licensing and distribution program for its anaesthesia portfolio, including its Byfavo™ injectable product.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Tasmina Goraya
Practice head
Adrian Toutoungi
Other key lawyers
Tasmina Goraya; Colin McCall; Charlie Adams